Methods for modulating mannose content of recombinant proteins

Patent metadata

Field	Value
Publication number	US-9359435-B2
Application number	US-201313741280-A
Country	US
Kind code	B2
Filing date	Jan 14, 2013
Priority date	Jan 23, 2006
Publication date	Jun 7, 2016
Grant date	Jun 7, 2016

Abstract

The present invention relates to methods of modulating (e.g., reducing) the mannose content, particularly high-mannose content of recombinant glycoproteins.

First claim

What is claimed is:

1. A method of producing a recombinant antibody, or an antigen-binding fragment thereof, comprising culturing a host-cell which expresses the recombinant antibody or antigen-binding fragment thereof in a culture medium having an osmolality of about 400 mOsm/Kg or less, wherein (i) the culture medium comprises a salt selected from the group consisting of potassium at a concentration of about 70 mM or less, sodium at a concentration of about 200 mM or less, and combinations thereof, (ii) the culture medium is substantially free of one or more amino acids selected from the group consisting of alanine, arginine, aspartic acid and glutamic acid, (iii) the culture medium comprises an osmoprotectant selected from the group consisting of betaine, glycine, L-threonine, L-proline, and derivatives thereof, and (iv) fewer than about 10% of the recombinant antibody molecules in the composition have more than 4 mannose residues.

2. The method of claim 1 , wherein the osmolality of the culture medium is between about 250 and about 380 mOsm/Kg.

3. The method claim 1 or 2 , wherein the culture medium comprises a salt selected from the group consisting of:
(a) potassium at a concentration of about 10 mM to about 50 mM;
(b) sodium at a concentration of about 50 mM to about 100 mM; and
(c) combinations of (a) and (b).

4. The method of claim 1 or 2 , wherein the culture medium comprises one or more vitamins selected from the group consisting of biotin, D-calcium pantothenate, choline chloride, folic acid, i-inositol, niacinaminde, pyridoxal HCl, pyridoxine HCl, riboflavin, thiamine HCl and cyanocobalamin, at a concentration of about 0.00005 g/L to about 0.9 g/L.

5. The method of claim 1 or 2 , wherein the culture medium comprises glucose at a concentration of about 1 mM to about 90 mM.

6. The method of claim 1 or 2 , wherein the culture medium comprises one or more peptones selected from the group consisting of yeast extract, yeast hydrolysate, soy peptone, soy hydrolysate, wheat peptone and wheat hydrolysate, at a concentration of about 0.5 g/L to about 60 g/L.

7. The method of claim 1 or 2 , wherein the osmoprotectant is betaine at a concentration of about 1 mM to about 100 mM.

8. The method of claim 7 , wherein the betaine is present at a concentration from about 20 mM to about 30 mM.

9. The method of claim 1 or 2 , wherein the host-cell is cultured for a period of about 5 to about 14 days.

10. The method of claim 1 or 2 , wherein the host-cell is cultured at a temperature of about 31° C. to about 38° C.

11. The method of claim 1 or 2 , wherein the host cell is a mammalian cell.

12. The method of claim 11 , wherein the mammalian host cell is a CHO cell.

13. The method claim 1 or 2 , wherein said antibody is recovered from said culture medium after culturing.

14. A method of producing a recombinant antibody, or an antigen-binding fragment thereof, comprising culturing a host-cell which expresses the recombinant antibody or antigen-binding fragment thereof in a culture medium having an osmolality of about 400 mOsm/Kg or less, wherein the culture medium:
(i) comprises potassium at a concentration of about 10 mM to about 50 mM; sodium at a concentration of about 50 mM to about 100 mM; or a combination thereof;
(ii) is substantially free of one or more amino acids selected from the group consisting of alanine, arginine, aspartic acid and glutamic acid; and
(iii) comprises betaine present at a concentration of about 20 mM to about 30 mM,
wherein fewer than about 10% of the recombinant antibody molecules in the composition have more than 4 mannose residues.

15. The method of claim 14 , wherein the culture medium has an osmolality between about 250 mOsm/Kg and about 380 mOsm/Kg.

16. The method of claim 14 or 15 , wherein the culture medium comprises potassium at a concentration of about 10 mM to about 50 mM, and sodium at a concentration of about 50 mM to about 100 mM.

17. The method of claim 16 , wherein the host cell is a mammalian cell.

18. The method of claim 17 , wherein the mammalian host cell is a CHO cell.

19. The method of claim 16 , wherein said antibody is recovered from said culture medium after culturing.

Assignees

• Amgen Inc

Inventors

• Wu Jian
• Le Nicole
• De La Cruz Michael
• Flynn Gregory

Classifications

• A61P37/06

  Immunosuppressants, e.g. drugs for graft rejection · CPC title

• A61P7/00

  Drugs for disorders of the blood or the extracellular fluid · CPC title

• A61P37/08

  Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

• A61P9/00

  Drugs for disorders of the cardiovascular system · CPC title

• A61P31/00

  Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title